2020 Orthopedics This Week Spine Technology Award Goes to SurGenTec

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

Quality Institute Again Earns Certification as Provider-Led Entity for Advanced Diagnostic Imaging Guidance to Clinicians.

LX1550 Multiparameter Remote Monitoring Platform Receives FDA 510 (k) Approval: Reports LifeSignals

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay's top hospital.

November 25, 2020

2020 Orthopedics This Week Spine Technology Award is generally presented during the North American Spine Society (NASS) annual meeting but was presented virtually this year.

The annual awards are voted on by a panel of highly accomplished neurosurgeons and orthopedic spine surgeons. The award is graded on originality, clinical relevance, the likelihood of improving patient outcomes, cost-effectiveness, and if the surgeon judging would use the technology. The awarded technology from SurGenTec’s product line is the unique and innovative 3D Fusion System™. The system allows physicians to access the facet joints and transverse process in an open or minimally invasive manner to decorticate and deliver bone graft. The system helps aid physicians when performing a true posterolateral lumbar fusion. Until now, there has never been an FDA cleared product available for physicians to use in spine surgery.

In minimally invasive lumbar fusion surgery this procedure is generally neglected due to access issues. SurGenTec aims to make its standard protocol in minimally invasive surgery, as it is in open procedures. The system combines the GraftGun® universal bone graft delivery system with the 3D GraftRasp™. These devices in conjunction allow for tactile decortication of bone and controlled graft delivery to the surgical site. There are multiple rasp options to use depending on the anatomical level and the rasp footplates are disposable to ensure the teeth are sharp for every case.

With this universal system, physicians may load the bone graft of their choice or use SurGenTec’s pre-filled GraftGun cartridges with ViMax™ (cellular matrix), OsteoFlo® NanoPutty® (synthetic bone graft), Ossify™ (Cortical Fibers, or DBM Putty) to reduce OR time and the risk of cross-contamination on the back table. SurGenTec recently received 510k clearance from the FDA for spine indications on top of their previously granted general orthopedic clearance. Multiple training labs are scheduled every month which feature didactic, dry lab and wet labs at the new Boca BioSkills Lab at their headquarters in Boca Raton, FL. SurGenTec’s 3D fusion system is currently being used within the US market and plans to introduce internationally

2020 Orthopedics This Week Spine Technology Award: Travis Greenhalgh, CEO of SurGenTec stated in a recent interview, “This award is a great honor for our company. We pride ourselves on developing new technologies to help physicians treat their patients with less-invasive treatment options. The 3D fusion system is a perfect example of perseverance and determination through years of research and development. We are humbled to be honored by the judges who are thought leading neurosurgeons and orthopedic surgeons in the spine surgery community. This is an exciting time for our company to release this first-of-its kind technology,” said Greenhalgh.

SurGenTec is a privately owned medical device company based in Boca Raton, Florida that is focused on unique technologies for the orthopedic and spine fields. SurGenTec develops and manufactures medical devices sold within the US and internationally. In 2018, SurGenTec received the Spine Technology Award for their ALARA™ target needle system presented at NASS (North American Spine Society) in Los Angeles, CA. They received clearance earlier this year for OsteoFlo NanoPutty a quadphasic synthetic bone graft which is under product launch.




Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.